Our portfolio meets key global health needs, bridging the gap between clinical care and at-home testing. Each product reflects our mission: accessible innovation that supports equitable health outcomes.
Our molecular diagnostics platform brings lab-quality nucleic acid testing to the point of care and the home. Designed for speed, accuracy and ease of use, these devices detect pathogens at the molecular level, providing clinically reliable results in minutes rather than hours.
Connected lateral flow testing with digital readout eliminates the guesswork of visual interpretation. Our digital lateral flow platform combines the simplicity of traditional test strips with electronic readers that deliver clear, objective results and seamless data connectivity.
We are reimagining blood collection to remove barriers to routine monitoring and diagnostic testing. Our at-home collection systems make it possible for anyone to collect high-quality samples from the comfort of their own home, improving access for people in remote and underserved communities.
Our lateral flow platform is engineered for extreme manufacturing scale and ultra-low costs, purpose-built for the realities of global health. These high-volume tests deliver reliable performance for the populations who need accessible diagnostics most.
